advertisement
Study: ACE inhibitors as effective as pricier meds
A large international study has found that treatment with an angiotensin-converting enzyme (ACE) inhibitor may be as effective as a newer, more expensive angiotensin-receptor blocker (ARB) drug. The study of more than 17,000 people with coronary artery disease or diabetes found no major differences in the reduction of heart attack, stroke, or death between those treated with the widely used ACE inhibitor Altace and those given the ARB Micardis. Experts say this finding might reduce the use of ARBs in some high-risk patients.
(HealthDay News) UPDATED 03/31/2008Click here to read the full story
advertisement
